Skip to main content

Table 3 Comparison between the two groups as regards the age (in years), weight (in kilograms), and indication for UFH (in numbers)

From: The use of activated partial thromboplastin time versus antifactor Xa assay in monitoring continuous unfractionated heparin infusion therapy in obstetric intensive care unit

Parameter Group P (n = 50) Group X (n = 50) p value
Age (years) 26.65 ± 4.5 24.84 ± 3.4 0.4776
Weight (kg) 83.2 ± 6.7 83.2 ± 8.6 0.98
Indications for UFH:
 Valvular heart disease 22 24 0.5277
 Atrial fibrillation 17 16 0.4807
 Anti-phospholipid syndrome 7 4 0.3305
 Venous thromboembolism 4 6 0.625
  1. Data presented as mean ± SD and numbers as appropriate, p value < 0.05 was considered statistically significant
\